These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2807157)

  • 1. Endotoxin-induced ascites formation in the rat: partial mediation by platelet-activating factor.
    Guarner F; Wallace JL; MacNaughton WK; Ibbotson GC; Arroyo V; Rodés J
    Hepatology; 1989 Nov; 10(5):788-94. PubMed ID: 2807157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for platelet-activating factor as a mediator of endotoxin-induced gastrointestinal damage in the rat. Effects of three platelet-activating factor antagonists.
    Wallace JL; Steel G; Whittle BJ; Lagente V; Vargaftig B
    Gastroenterology; 1987 Oct; 93(4):765-73. PubMed ID: 3305134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of prostaglandin E2 in endotoxic shock are unrelated to effects on PAF-acether synthesis.
    Ibbotson GC; Wallace JL
    Prostaglandins; 1989 Feb; 37(2):237-50. PubMed ID: 2727308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.
    Terashita Z; Kawamura M; Takatani M; Tsushima S; Imura Y; Nishikawa K
    J Pharmacol Exp Ther; 1992 Feb; 260(2):748-55. PubMed ID: 1738121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-activating factor: an endogenous mediator for bowel necrosis in endotoxemia.
    Hsueh W; González-Crussi F; Arroyave JL
    FASEB J; 1987 Nov; 1(5):403-5. PubMed ID: 3678700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effect of a platelet-activating factor antagonist, WEB 2086, on endotoxin-induced lung injury.
    Chang SW; Fernyak S; Voelkel NF
    Am J Physiol; 1990 Jan; 258(1 Pt 2):H153-8. PubMed ID: 2301603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a platelet-activating factor antagonist, CV-3988, on different shock models in the rat.
    Toth PD; Mikulaschek AW
    Circ Shock; 1986; 20(3):193-203. PubMed ID: 3802423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats.
    Chang SW; Feddersen CO; Henson PM; Voelkel NF
    J Clin Invest; 1987 May; 79(5):1498-509. PubMed ID: 3553241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal plasma leakage in endotoxic shock. Inhibition by prostaglandin E2 and by a platelet-activating factor antagonist.
    Wallace JL; Steel G; Whittle BJ
    Can J Physiol Pharmacol; 1987 Jul; 65(7):1428-32. PubMed ID: 3478114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet activating factor induced gastric damage in rats: participation of increased gastric vascular permeability.
    Hatakeyama K; Yano S; Watanabe K
    Scand J Gastroenterol Suppl; 1989; 162():71-4. PubMed ID: 2595312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-activating factor mediates endotoxin-induced acute renal insufficiency in rats.
    Wang J; Dunn MJ
    Am J Physiol; 1987 Dec; 253(6 Pt 2):F1283-9. PubMed ID: 2827506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of dexamethasone in endotoxic shock and its relation to PAF-acether synthesis in the gastrointestinal tract and lung.
    Ibbotson GC; Wallace JL
    J Lipid Mediat; 1989; 1(5):273-82. PubMed ID: 2519897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of platelet activating factor-induced glycogenolysis in the perfused rat liver after administration of endotoxin in vivo.
    Kimura K; Moriyama M; Nishisako M; Kannan Y; Shiota M; Sakurada K; Musashi M; Sugano T
    J Biochem; 1998 Jan; 123(1):142-9. PubMed ID: 9504421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of endotoxin-induced gastrointestinal damage by CV-3988, an antagonist of platelet-activating factor.
    Wallace JL; Whittle BJ
    Eur J Pharmacol; 1986 May; 124(1-2):209-10. PubMed ID: 3720841
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of platelet-activating factor antagonist SRI 63-441 on endotoxin-induced changes in rat mesenteric microcirculation.
    Li SH; Fei X; Gong XQ; Wu ZL
    Yao Xue Xue Bao; 1991; 26(1):6-9. PubMed ID: 1887797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric bleeding and increased gastric vascular permeability induced by platelet activating factor (PAF): effect of drugs that affect arachidonate metabolism.
    Hatakeyama K; Yano S; Watanabe K
    Jpn J Pharmacol; 1991 Jul; 56(3):271-7. PubMed ID: 1910120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential antagonism of platelet activating factor-induced neutrophilia and gastric hemorrhage in the rat.
    Thomas TK; Chesonis RS; Schmolze D; Symington J; Harbison ML; Walser A; Will PC
    Agents Actions; 1993; 39 Spec No():C195-7. PubMed ID: 8273566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Essential fatty acid-deficient diet modifies PAF levels in stomach and duodenum of endotoxin-treated rats.
    Autore G; Cicala C; Cirino G; Maiello FM; Mascolo N; Capasso F
    J Lipid Mediat Cell Signal; 1994 Mar; 9(2):145-53. PubMed ID: 8012761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Priming by platelet-activating factor of endotoxin-induced lung injury and cardiovascular shock.
    Rabinovici R; Esser KM; Lysko PG; Yue TL; Griswold DE; Hillegass LM; Bugelski PJ; Hallenbeck JM; Feuerstein G
    Circ Res; 1991 Jul; 69(1):12-25. PubMed ID: 1647275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms contributing to gastric motility changes induced by PAF-acether and endotoxin in rats.
    Esplugues JV; Whittle BJ
    Am J Physiol; 1989 Feb; 256(2 Pt 1):G275-82. PubMed ID: 2919672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.